These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 8842510)
1. Effects of transdermal nicotine patches on ambulatory ECG monitoring findings: a double-blind study in healthy smokers. Khoury Z; Comans P; Keren A; Lerer T; Gavish A; Tzivoni D Cardiovasc Drugs Ther; 1996 May; 10(2):179-84. PubMed ID: 8842510 [TBL] [Abstract][Full Text] [Related]
2. Cardiovascular safety of transdermal nicotine patches in patients with coronary artery disease who try to quit smoking. Tzivoni D; Keren A; Meyler S; Khoury Z; Lerer T; Brunel P Cardiovasc Drugs Ther; 1998 Jul; 12(3):239-44. PubMed ID: 9784902 [TBL] [Abstract][Full Text] [Related]
3. Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal. Teneggi V; Tiffany ST; Squassante L; Milleri S; Ziviani L; Bye A Psychopharmacology (Berl); 2002 Nov; 164(2):177-87. PubMed ID: 12404080 [TBL] [Abstract][Full Text] [Related]
4. Predicting smoking cessation. Who will quit with and without the nicotine patch. Kenford SL; Fiore MC; Jorenby DE; Smith SS; Wetter D; Baker TB JAMA; 1994 Feb; 271(8):589-94. PubMed ID: 8301790 [TBL] [Abstract][Full Text] [Related]
5. Nicotine replacement therapy for patients with coronary artery disease. Working Group for the Study of Transdermal Nicotine in Patients with Coronary artery disease. Arch Intern Med; 1994 May; 154(9):989-95. PubMed ID: 8179456 [TBL] [Abstract][Full Text] [Related]
6. Transdermal nicotine patches with low-intensity support to aid smoking cessation in outpatients in a general hospital. A placebo-controlled trial. Foulds J; Stapleton J; Hayward M; Russell MA; Feyerabend C; Fleming T; Costello J Arch Fam Med; 1993 Apr; 2(4):417-23. PubMed ID: 8130921 [TBL] [Abstract][Full Text] [Related]
7. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement. Hurt RD; Dale LC; Fredrickson PA; Caldwell CC; Lee GA; Offord KP; Lauger GG; Marŭsić Z; Neese LW; Lundberg TG JAMA; 1994 Feb; 271(8):595-600. PubMed ID: 8301791 [TBL] [Abstract][Full Text] [Related]
8. A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation. Prochazka AV; Kick S; Steinbrunn C; Miyoshi T; Fryer GE Arch Intern Med; 2004 Nov; 164(20):2229-33. PubMed ID: 15534159 [TBL] [Abstract][Full Text] [Related]
10. Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers. Ferguson SG; Gitchell JG; Shiffman S; Sembower MA Clin Ther; 2009 Sep; 31(9):1957-65. PubMed ID: 19843485 [TBL] [Abstract][Full Text] [Related]
11. Nicotine patches and the subjective effects of cigarette smoking: a pilot study. Cárdenas L; Busto UE; MacDonald A; Corrigall WA Can J Clin Pharmacol; 2002; 9(4):175-82. PubMed ID: 12584575 [TBL] [Abstract][Full Text] [Related]
12. Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial. Schuurmans MM; Diacon AH; van Biljon X; Bolliger CT Addiction; 2004 May; 99(5):634-40. PubMed ID: 15078238 [TBL] [Abstract][Full Text] [Related]
13. Randomized, double-blind, placebo-controlled study of transdermal nicotine patch for smoking cessation. Perng RP; Hsieh WC; Chen YM; Lu CC; Chiang SJ J Formos Med Assoc; 1998 Aug; 97(8):547-51. PubMed ID: 9747065 [TBL] [Abstract][Full Text] [Related]
14. [Effects of transdermal nicotine as an adjunct in smoking cessation therapy. A double-blind randomized study controlled with placebo]. Daughton DM; Heatley SA; Prendergast JJ; Causey D; Knowles M; Rolf CN; Cheney RA; Hatlelid K; Thompson AB; De Blasio F Arch Monaldi Mal Torace; 1992; 47(1-6):17-29. PubMed ID: 1306633 [TBL] [Abstract][Full Text] [Related]
15. Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial. Kornitzer M; Boutsen M; Dramaix M; Thijs J; Gustavsson G Prev Med; 1995 Jan; 24(1):41-7. PubMed ID: 7740014 [TBL] [Abstract][Full Text] [Related]
16. Varying nicotine patch dose and type of smoking cessation counseling. Jorenby DE; Smith SS; Fiore MC; Hurt RD; Offord KP; Croghan IT; Hays JT; Lewis SF; Baker TB JAMA; 1995 Nov; 274(17):1347-52. PubMed ID: 7563558 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of an over-the-counter transdermal nicotine patch as an aid for smoking cessation. Davidson M; Epstein M; Burt R; Schaefer C; Whitworth G; McDonald A Arch Fam Med; 1998; 7(6):569-74. PubMed ID: 9821833 [TBL] [Abstract][Full Text] [Related]
18. Transdermal nicotine for smoking cessation. Six-month results from two multicenter controlled clinical trials. Transdermal Nicotine Study Group. JAMA; 1991 Dec; 266(22):3133-8. PubMed ID: 1956099 [TBL] [Abstract][Full Text] [Related]